Patent · US Expired

Practical synthesis of benzoxazinones useful as HIV reverse transcriptase inhibitors

US6147210A · kind A · utility

2Cited by
4References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 1999
Grant dateNov 14, 2000
Priority date
Expiry dateJun 25, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/02
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention describes novel methods for the synthesis of benzoxazinone compounds which are useful as human immunodeficiency virus (HIV) reverse transcriptase inhibitors. The benzoxazinone of the formula: is particularly effective in the treatment of HIV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.